Tics Clinical Trials

149 recruitingLast updated: May 13, 2026

There are 149 actively recruiting tics clinical trials across 38 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 4, Phase 3. Top locations include Shanghai, Shanghai Municipality, China, Toronto, Ontario, Canada, Guangzhou, Guangdong, China. Updated daily from ClinicalTrials.gov.


Tics Trials at a Glance

149 actively recruiting trials for tics are listed on ClinicalTrialsFinder across 6 cities in 38 countries. The largest study group is Not Applicable with 46 trials, with the heaviest enrollment activity in Shanghai, Toronto, and Guangzhou. Lead sponsors running tics studies include Centre Hospitalier Universitaire, Amiens, Azienda Ospedaliera "Sant'Andrea", and Children's Hospital of Fudan University.

Browse tics trials by phase

Treatments under study

About Tics Clinical Trials

Looking for clinical trials for Tics? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Tics trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Tics clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 149 trials

Recruiting

Prospective Observational Multicenter Study of Patients With AH and CKD Markers in Kazakhstan (PROGRESS-CKD)

Rate of CKD Diagnosis in Patients With AH and CKD MarkersDemographic and Clinical Characteristics for Those PatientsRoutine Therapy Before and After the Diagnosis of CKD
AstraZeneca1,282 enrolled29 locationsNCT06744335
Recruiting

Distinguishing Tics and Functional Tics Using Clinical Neurophysiological Techniques

TicsFunctional Tics
National Institute of Neurological Disorders and Stroke (NINDS)75 enrolled1 locationNCT07137442
Recruiting
Not Applicable

Bundled Cancer Screening and Genetic Services Navigation

Breast Cancer ScreeningColon Cancer ScreeningGenetics Predisposition
Georgetown University820 enrolled2 locationsNCT07228000
Recruiting
Phase 2

Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD

Insulin ResistanceChronic Kidney DiseasesFatigue+4 more
University of California, Davis80 enrolled2 locationsNCT04984226
Recruiting

Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy

Turner SyndromeGalactosemiaPost-menarcheal Adolescents+3 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)200 enrolled1 locationNCT04948658
Recruiting

Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

Pseudomonas aeruginosaPrognosisPseudomonas Infections+3 more
Centre Hospitalier Régional d'Orléans600 enrolled48 locationsNCT06738771
Recruiting
Phase 4

Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies

AntibioticsPeriodontal DiseasesPharmacokinetics
University of Geneva, Switzerland45 enrolled1 locationNCT04669717
Recruiting

Natural History of Depression, Bipolar Disorder and Suicide Risk

Molecular Mechanisms of Pharmacological ActionDepressive SymptomsSuicide+18 more
National Institute of Mental Health (NIMH)500 enrolled1 locationNCT06462196
Recruiting
Phase 2Phase 3

Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers

PharmacokineticsPharmacodynamicsInsulin Aspart
Amphastar Pharmaceuticals, Inc.60 enrolled1 locationNCT07560150
Recruiting
Not Applicable

Antibiotic Prophylaxis for Ureteroscopy With a Negative Pressure Suction Sheath

AntibioticsUrolithiasis
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine500 enrolled1 locationNCT07246967
Recruiting
Phase 3

Nebulized Ketamine for the Treatment of Major Depressive Disorder

MidazolamDepressive SymptomSevere Depression+14 more
Theresa Jacob, PhD, MPH40 enrolled1 locationNCT06752759
Recruiting

ATTITUDES, PERCEPTIONS, AND COMPETENCIES TOWARDS ARTIFICIAL INTELLIGENCE IN ORTHOTICS AND PROSTHETICS

Artificial IntelligenceAttitudeHealthcare Professionals+4 more
gizem boztas175 enrolled1 locationNCT07547293
Recruiting

The Combined First Trimester Screening

Fetal Growth RestrictionPreterm LaborPreeclampsia (PE)+4 more
Institute of Health Information and Statistics of the Czech Republic2,000 enrolled3 locationsNCT07015203
Recruiting
Phase 1

Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose

Healthy ParticipantsPharmacokinetics
Amgen400 enrolled5 locationsNCT07422285
Recruiting

Nutritional Knowledge and Characteristics of HYROX Athletes

Assess Dietary Intake, Nutitional Knowledge, Eating Behaviours and Body Composition Characeristics in HIFT Athletes
University of Alicante122 enrolled1 locationNCT07531953
Recruiting
Phase 2

CBIT+TMS R33 Phase

Tourette SyndromeTics
University of Minnesota60 enrolled1 locationNCT06678737
Recruiting
Not Applicable

Effects of Antipsychotics on Brain Insulin Action in Females

Insulin ResistanceMenstrual CycleType 2 Diabetes+1 more
Centre for Addiction and Mental Health15 enrolled1 locationNCT06251635
Recruiting
Phase 4

The STOP-MED CTRCD Trial

Heart FailureCancerCardiotoxicity+2 more
Dinesh Thavendiranathan335 enrolled14 locationsNCT06183437
Recruiting
Phase 1

Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents

Pharmacokinetics After Oral Intake
Iterum Therapeutics, International Limited12 enrolled1 locationNCT07092813
Recruiting
Not Applicable

Spot Analysis of Natriuresis to Guide up- or Down-titration of Diuretic Therapy in Ambulatory Patients With Chronic Heart Failure

Heart FailureDiuretics
Cardiology Research UBC300 enrolled1 locationNCT07369856